Accession Number: | 0001735276-20-000082 |
Date: | 2020-07-01 |
Issuer: | ALNYLAM PHARMACEUTICALS, INC. (ALNY) |
Original Submission Date: |
HAMBURG MARGARET A
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 148.77 | 2020-07-01 | deemed execution date | A | 4,581 (a) | 2021-07-01 | 2030-07-01 | common stock 4,581 | $148.77 | 4,581 | direct |
ID | footnote |
---|